DANTROLENE 120 MG POWDER FOR SOLUTION FOR INJECTION IV

This tender pertains to the procurement of Dantrolene 120 mg, which is a medication used primarily for the treatment of malignant hyperthermia and certain muscle disorders. The product is required in powdered form for reconstitution into a solution intended for intravenous injection. The tender specifies the need for high-quality pharmaceutical standards, ensuring that the product meets all regulatory requirements for safety and efficacy. It is essential that the supplier can demonstrate compliance with Good Manufacturing Practices (GMP) and provide relevant certifications. The location for delivery is not explicitly stated in the tender, but it is implied that the product will be used in healthcare facilities that require immediate access to this critical medication. Interested suppliers are expected to submit their bids along with detailed information about their manufacturing processes, quality control measures, and delivery timelines. The tender highlights the importance of timely delivery and the ability to meet fluctuating demand, given the nature of the medication's use in emergency situations. Overall, this procurement is vital for ensuring that healthcare providers have access to necessary treatments for patients experiencing severe medical conditions.

This is a supplies contract in the health and medical services, transport and logistics and trade and industry sectors, with a focus on Pharmaceuticals, Logistics, Manufacturing and Quality Standards. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2,761.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.